4/A
Changes in Ownership
NRX Pharmaceuticals, Inc. Filed Acc 0001415889-22-012650
CHIEF FINANCIAL OFFICER bought 16,337 shares at an average $1.11 ($18,215)
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X03/form4a-12192022_121206.xml…